Results 21 to 30 of about 296,701 (305)
Purpose To investigate the safety and efficacy of Enterprise stent angioplasty and risk factors for the prognoses in treating symptomatic severe posterior circulation atherosclerotic stenosis (SSPCAS).
Zhi-Long Zhou +8 more
doaj +1 more source
Stent-in-Stent Endovascular Correction in Right Internal Carotid Artery Restenosis: a Clinical Case
Background. Carotid artery restenosis is a rare complication of carotid stenting. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) reveals an in-stent restenosis rate of 0–6 %, a fairly low value given an extensive study ...
T. N. Khafizov +6 more
doaj +1 more source
Reply to Letter to the Editor: "Comments on 'Evaluation of Whole Blood Viscosity to Predict Stent Restenosis'". [PDF]
Çalapkulu Y.
europepmc +3 more sources
Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model. [PDF]
Preclinical models of restenosis are essential to unravel the pathophysiological processes that lead to in-stent restenosis and to optimize existing and future drug-eluting stents. A variety of antibodies and transgenic and knockout strains are available
Deuse, Tobias +3 more
core +2 more sources
OBJECTIVES In-stent restenosis (ISR) is one of the main long-term complications after coronary stent placement, and the ability to evaluate ISR noninvasively using coronary computed tomography (CT) angiography remains challenging.
G. Bratke +9 more
semanticscholar +1 more source
Iron corroded granules inhibiting vascular smooth muscle cell proliferation
In-stent restenosis after interventional therapy remains a severe clinical complication. Current evidence indicates that neointimal hyperplasia induced by vascular smooth muscle cell (VSMC) proliferation is a major cause of restenosis.
Dongxu Qiu +9 more
doaj +1 more source
Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]
<p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H. +10 more
core +1 more source
A polymer coated cicaprost-eluting stent increases neointima formation and impairs vessel function in the rabbit iliac artery [PDF]
Drug-eluting stents have been successful in reducing in-stent restenosis but are not suitable for all lesion types and have been implicated in causing late stent thrombosis due to incomplete regeneration of the endothelial cell layer.
Jones, Robert L. +4 more
core +2 more sources
The Mechanisms of Restenosis and Relevance to Next Generation Stent Design
Stents are lifesaving mechanical devices that re-establish essential blood flow to the coronary circulation after significant vessel occlusion due to coronary vessel disease or thrombolytic blockade.
Jessie Clare +5 more
semanticscholar +1 more source
Objective: To study the frequency of In-Stent Restenosis and its treatment in patients undergoing Percutaneous Coronary Intervention for coronary artery disease. Study Design: Descriptive cross sectional study.
Waseem Raja +7 more
doaj +1 more source

